Nephron Assumes Elevance (ELV) at Hold
Nephron analyst Eric Percher assumes coverage on Elevance (NYSE: ELV) ...
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
